Taken together, these discoveries imply that orexin-A has the potential to alleviate cerebral ischemia–reperfusion injury by inhibiting apoptosis mediated by ERS, thereby elucidating the mechanism underlying its neuroprotective properties (Table 2). This evidence concerns the gene HCRT and Cerebral ischemia.